AstraZeneca’s Post

Better healthcare starts here: The University of Ottawa’s new Advanced Medical Research Centre (AMRC) will play a crucial role in curbing Ottawa’s biotech brain drain. Ottawa has earned its global reputation as a vibrant city for medical research and innovation. But if it wants to keep its top researchers in the region and build a thriving biotech sector, more lab space and private investment will be needed, says Jean-Simon Diallo, who is founder and CEO of Virica Biotech Inc, scientist at the Ottawa Hospital Research Institute, and associate professor at the uOttawa | Faculté de médecine | Faculty of Medicine. At the Advanced Medical Research Centre (AMRC), researchers, health-care professionals and investors will team up to accelerate the discovery and commercialization of life-saving therapies.  “The AMRC is a good example of the understanding that we need to get researchers to commercialize their intellectual property. But we also need to support them with the space and the equipment they need.” says Dane Bedward, CEO of NeuroBot Inc. and former senior vice president international for Genzyme Corporation. “There’s so much grey matter here, but so many inventions that have come out of Canada get gobbled up and taken outside Canada.” Read the article or watch the video to learn more about how the AMRC will provide huge opportunities for the next wave of Ottawa biotech researchers and entrepreneurs. - https://lnkd.in/g46-G9Au #uOttawa #uOttawaAMRC #BetterHealthcare #StartsHere #Ottawa #research #biotech

🌟 Great presentations by Yike Xie, Evgeniia Shcherbinina, Gayathri Narasimhan, and Angana Patel (who presented in place of Nadia Gul) during the WCMTM and AstraZeneca postdoc seminar in April! In this industry postdoc program, a PI from each organization joins forces with a shared postdoctoral researcher. Together they conduct a research project focused on innovation and health benefits. While presenting methodologies, results, and timelines, the postdocs also underscored a vital aspect: the invaluable access to both the university and the AstraZeneca labs, capabilities, and network. Pernille B. Laerkegaard Hansen who is Executive Director and Head of Bioscience Renal and CVRM at AstraZeneca, was one of the participants at the seminar: “The joint postdoc program is intended as a close collaboration allowing the researchers to work as one single team, although placed in different organizations and locations,” Pernille said. Learn more about the seminar and the ongoing projects at our website https://lnkd.in/dPBaXpgd #innovation #healthinnovation #lifescience #academy #industry #collaboration #astrazeneca #wcmtm #postdoc #

As a high-tech, research-intensive sector crucial for innovation, economic growth, and public health, the life sciences deserve a central role in the EU’s competitiveness agenda, and that’s why we welcome EFPIA’s proposal for a dedicated European Industrial Strategy. A strong life sciences ecosystem benefits all EU citizens. New discoveries and technologies bring earlier and better diagnoses, create new patient treatments and make care more beneficial and comforting. Thanks to life science innovation, people in Europe and throughout the world are being supported to live longer, healthier and happier. However, Europe’s leadership is being challenged by global competition, underscoring the need for policies that attract strategic investments and maintain the continent’s edge in medical innovation. There should be a clear vision to position Europe as a world-leader in science, innovation, and modern manufacturing, prioritizing the needs of patients and society. EFPIA’s proposal for a dedicated EU life sciences strategy is a timely and important step to strengthen Europe’s competitiveness and resilience in this critical sector. I hope EU policymakers will give this proposal serious consideration. https://lnkd.in/eyfcPD8q

Driving Innovation in Precision Medicine The School of Engineering at Ulster University is proud to be part of the ground-breaking £55 million Future Medicines Institute (FMI), an initiative poised to revolutionise the Life and Health Sciences sector in Northern Ireland. Backed by a consortium of industry leaders and supported by Queen's University Belfast and Ulster University, FMI will accelerate advancements in diagnostics, therapeutics, and personalised medicine. Department for the Economy NI Minister Murphy highlighted the £55 million investment in the Future Medicines Institute as a landmark for Precision Medicine in Northern Ireland, fostering collaboration across sectors to drive economic growth and accelerate access to personalised treatments. Professor Paul Bartholomew, Vice-Chancellor of Ulster University, emphasized the role of our Centre for Digital Health Technology (CDHT) in supporting FMI's partners and driving innovation in MedTech, AI, biomolecular innovation, and healthcare diagnostics. Together, we’re shaping the future of global healthcare innovation. #PrecisionMedicine #EngineeringInnovation #Collaboration #LifeSciences #UlsterUniversity #FMI

🇩🇰 Denmark’s Life Science Strategy: Paves the Way for Future Innovation Important things are happening in Denmark with the new Life Science Strategy being effective up until 2030. The government has allocated 72.8 million DKK for the 2023-2026 period to the Erhvervsfyrtårn Life Science, an initiative to strengthen public-private partnerships in healthcare. Led by Novo Nordisk, Lundbeck, the Capital Region Business Hub, and the Danish Life Science Cluster. I am very optimistic about this new strategy, here is my key takeaways from the new strategy: 1. 📈 With greater access to venture capital and targeted collaboration across research, healthcare, and industry, new ventures are better positioned to make an impact and scale globally. 2. 🤖 Leveraging unparalleled health data and accelerating AI applications, Denmark is leading in transformative, data-driven research. With strengthened frameworks for clinical research, the country is making strides in personalized medicine and advanced health solutions. 3. ⏩ Denmark is committed to fast-tracking the adoption of cutting-edge solutions. From workforce-saving technologies to advanced medical tools, their healthcare system is set to stay resilient and efficient, backed by a collaborative ecosystem. Neurora, Thomas Ousterhout Ph.D., Jakob T. Sutton

SAVE THE DATE 5th Nordic #RealWorldEvidence and #AI conference 28-29.1.2025 in the main building of the University of Helsinki. We continue the tradition of #RWE conferences, this time the organizers are University of Helsinki and Åbo Akademi University #NordicPharmaTrain #NordicPOP. Thanks to committed Sponsors we aim to offer the conference free of charge to all participants (but No Show Fee). The goal is to increase the Nordic opportunities and the attractiveness of the #Nordic Region and #EU for conducting #research, finding new solutions to challenges and to be in the forefront of progress. The #Networking between the Stakeholder and Country representatives from the Nordic and other European countries as well as US is also playing a vital role, and therefore the conference is designed to be a two day on site #f2fconference. The Helsingin kaupunki – Helsingfors stad – City of Helsinki has invited us to the City Hall for a #NetworkingEvent. The preliminary program is under constructions and your input is highly appreciated - be active and send suggestions. So far: presentations, from Vendors, Sponsors, Academia, Pharma, Healthcare, Regulators, HTA/regulatory bodies. RWE in #valuebasedhealthcare. How will Regulators, HTA bodies, and Payers use RWD and AI for assessment and approval –  for improving healthcare/treatment outcomes of medicine. Use of Genomics and Data to improve R&D. Boost #clinicaltrials using #EHR, #Registries, #biobanks #EDHEN #DARWIN-EU #EHDS #TEHDAS2 #VALO #OMOP Use of data in #Hospitaldecisionmaking EFPIA - European Federation of Pharmaceutical Industries and Associations Erkki Soini Tero Ylisaukko-oja Markus Kalliola Monica Larsen Lääketeollisuus ry / Pharma Industry Finland Pekka Ihalmo Martta Ranta Sini Eskola Nadia Tamminen Maija Wolf Elina Wiik Juha Laine Karolina Antonov Jakob Bjerg Larsen Maria Virkki, MD, PhD, EMBA Anne Juppo Jessica Rosenholm NordForsk The photo by Emilia Bengtström reflects the state of the Program, still some help needed

Today the Department for the Economy NI Minister Conor Murphy announced the Future Medicines Institute (FMI), a £55million collaborative initiative between 7 key industry leaders with one aim to advance precision medicine in Northern Ireland and beyond. This collaboration provides an opportunity to showcase the commitment to healthcare, the development of cutting-edge technologies and collaborative R&D activities that shape the future for life and health sciences. Discover more - https://lnkd.in/eE9JqMm9 Queen's University Belfast | Ulster University | Department for the Economy NI | Diaceutics PLC | Fusion Antibodies | Almac Group | Sonrai | Exploristics | Transforming Clinical Trial Design | ProAxsis

🌍 Life Science Industry in the UK and EU: A Market on the Rise 🚀 The life science sector in the UK and Europe is experiencing unprecedented growth, cementing its role as a global leader in innovation and healthcare advancements. With a market valued at hundreds of billions of euros, the region is at the forefront of driving breakthroughs in biotechnology, pharmaceuticals, and medical technology. 🔬 The UK has emerged as a top destination for biotech investment, with London and Cambridge leading the way in cutting-edge research and clinical trials. The government's life sciences strategy, combined with regulatory agility, is creating a favorable environment for companies to scale and bring life-changing therapies to market quickly. 🇪🇺 Across Europe, countries like Germany, France, and Switzerland are strengthening their positions in the industry through substantial R&D funding and government support. The EU's emphasis on collaboration and cross-border partnerships accelerates the development of innovations in personalized medicine, AI, and digital health. 💡 The market is also seeing a shift towards sustainability and green practices, with initiatives like the European Green Deal driving companies to align with environmental goals. 🌱 Despite economic challenges, the life sciences sector in the UK and Europe continues to attract talent and investment, shaping the future of healthcare and driving better patient outcomes globally. 🚀🔬🌍 To find out more about the current opportunities we are recruiting in the Life Science industry, head to our website 💻 https://lnkd.in/enuuCf5C #LifeScience #LifeScienceNews #LifeScienceJobs

Collaborating and exchanging ideas across international borders drives scientific advancement and accelerates research. This important partnership with colleagues in Switzerland will help us work together to unlock new ways to treat patients, diagnose illnesses and make the most of new health technology.

We’re thrilled to invite you to the Dutch Life Sciences conference on December 12 at Leiden Bio Science Park in the CORPUS Congress Centre! 🌐 It will be a great annual gathering for both Dutch and international leaders in biotech, pharma, medical devices, R&D, academia, and investment. This year’s conference will dive into 8 key topics, with a consistent focus on scaling up through innovation, partnerships, and business strategies to shape a healthier, more sustainable future. 🌱 A glimpse from the program: 💡 Impact Investing: How it strengthens the value proposition for entrepreneurs 🔍 Strategic Decisions for Medical Device Companies: Independence or partnerships? 🧬 Cell Therapy Advancements: Investment landscape and clinical insights 💰 Financial Strategies: Extending runway and reducing costs 🌱  Sustainability Challenges in Life Sciences Speakers include Wiro Niessen, Captain of Science of Top Sector Life Sciences & Health, on the successful and responsible implementation of AI in healthcare. Moreover, the announcement of the Venture Challenge Fall Winner 2024 will be done by our colleague Chretien Herben.🏅 For more information: https://lnkd.in/e262QAuH. #DutchLifeSciencesConference #LifeSciences #Innovation #DLS2024 Iventus